Thus, these results suggested that peptide-I increased macrophage foam cell formation and atherosclerosis progression by disrupting the interaction between USP9X and SR-A1, which mimicked the proatherosclerotic effect of USP9X deficiency. This evidence concerns the gene USP9X and atherosclerosis.